“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”
Mineralys is a fully remote company.
Director, Market Research & Competitive Intelligence
Position Summary:
The Director, Market Research & Competitive Intelligence will be responsible for primary & secondary market research/analytics & competitive intelligence to support the development & launch of lorundrostat.
- Create strategic frameworks to help Mineralys organize & prioritize key business questions around commercial planning, lifecycle management,
- Proactively manage multiple third-party vendors, data providers & consultants to generate insights & data to support key business decisions for the organization including commercial as well as various cross functional partners.
- Work with marketing & market access to develop strategic commercial plan for the launch of lorundrostat in uncontrolled / resistant hypertension.
- Answer or provide commercial perspective on ad hoc literature review / epidemiology / commercial opportunity related questions to support BD, senior leadership questions, external presentations (for investors, earnings, etc.), BoD presentations, Leadership Team presentations
- Monitor and disseminate competitive activity in TAs of interest to broader organization
- Provide input on revenue forecast updates/development
- Efficiently manage business insights budget planning & spend
- This role will report to Exec. Director of Business Analytics & CI.
Skills and Attributes
- PowerPoint, Excel, presentation skills (Expertise in creating clear & attractive presentations & frameworks is required & critical for this role)
- Strong knowledge of US pharmaceutical market (preferably in general medicine, cardiovascular, metabolic, renal, or other larger prevalence therapeutic areas)
- Some knowledge/experience with US payer/market access environment and data sources is preferred.
- Some knowledge/experience of major ex-US pharmaceutical markets is preferred but not required.
- Working experience with US data sources for market data (claims/EHR/Rx/audits/Payer Coverage/CI DBs) is required.
- Working knowledge of drug development process and ability to evaluate competitive clinical trial design is required
Education and Experience
- Bachelor’s degree or equivalent experience required
- Minimum of 8 years in market research, data analytics, business intelligence, competitive intelligence, marketing or other related discipline within commercial pharmaceutical or biotech located in the US
Travel:
- This position requires up to 10% travel. Frequently travel is outside the local area and overnight.
US Salary Range: $190,000 - $220,000
#LI-Remote
Skills Required
- Bachelor’s degree or equivalent experience
- Minimum 8 years of experience in market research, data analytics, business intelligence, competitive intelligence, marketing, or a related discipline within U.S. commercial pharmaceutical or biotech
- Expertise with Microsoft PowerPoint and Microsoft Excel
- Strong knowledge of the U.S. pharmaceutical market
- Working experience with U.S. market data sources, including claims, EHR, prescription, audit, payer coverage, and competitive intelligence databases
- Working knowledge of the drug development process and ability to evaluate competitive clinical trial design
- Strong presentation skills and ability to create clear, attractive presentations and strategic frameworks
- Knowledge or experience with the U.S. payer and market access environment and data sources
- Knowledge or experience with major ex-U.S. pharmaceutical markets
What We Do
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing lorundrostat, a proprietary oral aldosterone synthase inhibitor, to treat uncontrolled and resistant hypertension and related cardiorenal disorders (including CKD and OSA). The company focuses on targeted therapies for diseases driven by dysregulated aldosterone and is advancing late-stage clinical programs and regulatory filings to bring this treatment to patients.
